R H Singer|M R Green - JoVE Visualize

Showing results (331-340 of 417) with videos related to

Pageof 42

Sort By:

Cancer|October 15, 1985

Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphomaR E Sobol, R O Dillman, H Collins, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1977

Synthesis and secretion of a high molecular weight form of nerve growth factor by skeletal muscle cells in cultureR A Murphy, R H Singer, J D Saide, et al.

Chest|March 27, 1998

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group BJ E Herndon, M R Green, A P Chahinian, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2014

BSACI guideline for the diagnosis and management of cow's milk allergyD Luyt, H Ball, N Makwana, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 1, 1993

The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genesB Ohana, P A Moore, S M Ruben, et al.

Seminars in Oncology|August 1, 1997

A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancerH B Neill, A A Miller, G H Clamon, et al.

Molecular Cell|December 9, 1998

Broad, but not universal, transcriptional requirement for yTAFII17, a histone H3-like TAFII present in TFIID and SAGAL M Apone, C A Virbasius, F C Holstege, et al.

Cancer|November 26, 1999

Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group BH L Kindler, C P Belani, J E Herndon, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1983

Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlationsR O Dillman, J C Beauregard, J W Lea, et al.

Cancer Investigation|January 1, 1994

A feasibility study of extended chemotherapy for locally advanced non-small cell lung cancer: a phase II trial of cancer and leukemia group BG Clamon, J Herndon, W Eaton, et al.

Pageof 42

Showing results (331-340 of 417) with videos related to

Sort By:

Pageof 42

Cancer|October 15, 1985

Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphomaR E Sobol, R O Dillman, H Collins, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1977

Synthesis and secretion of a high molecular weight form of nerve growth factor by skeletal muscle cells in cultureR A Murphy, R H Singer, J D Saide, et al.

Chest|March 27, 1998

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group BJ E Herndon, M R Green, A P Chahinian, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2014

BSACI guideline for the diagnosis and management of cow's milk allergyD Luyt, H Ball, N Makwana, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 1, 1993

The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genesB Ohana, P A Moore, S M Ruben, et al.

Seminars in Oncology|August 1, 1997

A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancerH B Neill, A A Miller, G H Clamon, et al.

Molecular Cell|December 9, 1998

Broad, but not universal, transcriptional requirement for yTAFII17, a histone H3-like TAFII present in TFIID and SAGAL M Apone, C A Virbasius, F C Holstege, et al.

Cancer|November 26, 1999

Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group BH L Kindler, C P Belani, J E Herndon, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1983

Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlationsR O Dillman, J C Beauregard, J W Lea, et al.

Cancer Investigation|January 1, 1994

A feasibility study of extended chemotherapy for locally advanced non-small cell lung cancer: a phase II trial of cancer and leukemia group BG Clamon, J Herndon, W Eaton, et al.

Pageof 42